跳到正文
原文
Medical Xpress·· 1 天前精选AI 评分65

69000多名年轻患者分析质疑通用筛查阈值

Analysis of over 69,000 younger patients questions one-size-fits-all cutoff for colorectal cancer stool test

AI 导读

一项新研究发现,粪便免疫化学测试(FIT)在年轻患者中的表现与50岁以上患者不同,需要个体化评估阈值以提高诊断准确性。研究团队分析了69000多名年轻患者的FIT结果,发现年轻患者中结直肠癌的诊断率远低于50岁以上患者。

推荐理由

研究团队分析了大量数据,发现不同年龄段的 FIT 结果需要个体化评估。

正文
bowel
Credit: Pixabay/CC0 Public Domain

A new study led by experts at the University of Nottingham has provided new insight into how a commonly used test for colorectal cancer performs in people under 50.

Colorectal cancer is the fourth most common cancer and second-leading cause of cancer death in the U.K. (according to Cancer Research UK). Globally, there has been a concerning increase in "early-onset" colorectal cancer (i.e., a diagnosis before age 50), which highlights the importance of improving diagnosis in younger people.

This new study, published in the journal Gut, looked at whether FITs (fecal immunochemical tests) are effective tests for bowel cancer (colorectal cancer) in people under 50.

The study was led by professor David Humes in the School of Medicine and NIHR Nottingham Biomedical Research Centre and supported by international collaborators including COLOREACH-UK and the U.S.-based charity Fight Colorectal Cancer.

The results indicate that further work is needed to understand how a person's age should be considered alongside their FIT results to better determine colorectal cancer risk and prioritize investigation of those most at risk.

A shared cutoff across age groups

FITs are used by general practitioners to detect microscopic traces of blood in the stool of people who have symptoms of colorectal cancer. If the test is "negative," then the risk of colorectal cancer is very low, and no further tests are needed.

If the FIT result is 10 or above, patients are referred to the hospital for urgent further tests, such as a camera test (colonoscopy), which is invasive and can be uncomfortable.

Colorectal cancer risk varies greatly by age group, yet most research has focused on patients over 50. In this new study, experts looked at how well FIT works in patients under 50 at the current cutoff of 10.

Lower cancer rates in younger patients

The research team reviewed all available research on FIT in people under 50 who had symptoms that could be caused by colorectal cancer and compared the findings with those for patients over 50.

They found 12 studies that included more than 69,000 people under 50 with symptoms who were tested with FIT. In those under 50 who had a FIT, only about 1 in 300 (0.35%) were diagnosed with colorectal cancer. In people over 50, the risk was three to seven times higher.

Tailoring referrals to cancer risk

The findings show that FIT is a good test for diagnosing colorectal cancer; however, using the same FIT threshold of 10 may not work equally well for all age groups. Many more people under 50 would need to undergo further invasive tests to find one case of colorectal cancer compared with older adults, and therefore further research is required to tailor these cutoffs so the right patients can be prioritized to accelerate diagnosis.

Humes, the senior author of the research, said, "For the first time, our international research brings together the current evidence base for using stool tests in the diagnosis of patients with symptoms of suspected colorectal cancer with a particular focus on how the test performs by age. Further work is now needed to assess the optimum FIT cutoff or integration of FIT into individualized CRC risk prediction models in patients under 50 years and to examine alternative causes of a raised FIT in younger age groups."

Anjee Davis, MPPA, chief executive officer of Fight Colorectal Cancer, said, "Early-onset colorectal cancer is rising worldwide, and this is exactly the kind of question our Global Research Collaborative was built to answer. By pooling evidence across countries, this team has shown that one FIT threshold may not work equally well for every age group. Fight CRC is proud to have brought this group together, and we look forward to the next steps toward better, more tailored diagnosis for people under 50."

Publication details

Diagnostic performance of faecal immunochemical testing (FIT) for colorectal cancer in symptomatic patients under 50 years tested in primary care: a systematic review, Gut (2026). DOI: 10.1136/gutjnl-2026-339890

Journal information: Gut

Who's behind this story?

Swati Mestri

Swati Mestri

Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Analysis of over 69,000 younger patients questions one-size-fits-all cutoff for colorectal cancer stool test (2026, November 18) retrieved 18 November 2026 from https://medicalxpress.com/news/2026-11-analysis-younger-patients-size-cutoff.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com